vs
Side-by-side financial comparison of CROSS COUNTRY HEALTHCARE INC (CCRN) and Phillips Edison & Company, Inc. (PECO). Click either name above to swap in a different company.
CROSS COUNTRY HEALTHCARE INC is the larger business by last-quarter revenue ($236.8M vs $190.7M, roughly 1.2× Phillips Edison & Company, Inc.). Phillips Edison & Company, Inc. runs the higher net margin — 17.4% vs -35.0%, a 52.5% gap on every dollar of revenue. On growth, Phillips Edison & Company, Inc. posted the faster year-over-year revenue change (7.0% vs -23.6%). Over the past eight quarters, Phillips Edison & Company, Inc.'s revenue compounded faster (8.7% CAGR vs -21.0%).
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...
Consolidated Edison, Inc., commonly known as Con Edison or ConEd, is an energy company based in New York City. It is one of the largest investor-owned energy companies in the United States, with approximately $15.26 billion in annual revenues as of 2024, and over $70 billion in assets. The company provides a wide range of energy-related products and services to its customers through its subsidiaries:Consolidated Edison Company of New York, Inc. (CECONY), a regulated utility providing electric...
CCRN vs PECO — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $236.8M | $190.7M |
| Net Profit | $-82.9M | $33.2M |
| Gross Margin | — | — |
| Operating Margin | -30.2% | 30.5% |
| Net Margin | -35.0% | 17.4% |
| Revenue YoY | -23.6% | 7.0% |
| Net Profit YoY | -2109.7% | 15.1% |
| EPS (diluted) | $-2.56 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $190.7M | ||
| Q4 25 | $236.8M | $187.9M | ||
| Q3 25 | $250.1M | $182.7M | ||
| Q2 25 | $274.1M | $177.8M | ||
| Q1 25 | $293.4M | $178.3M | ||
| Q4 24 | $309.9M | $173.0M | ||
| Q3 24 | $315.1M | $165.5M | ||
| Q2 24 | $339.8M | $161.5M |
| Q1 26 | — | $33.2M | ||
| Q4 25 | $-82.9M | $47.5M | ||
| Q3 25 | $-4.8M | $24.7M | ||
| Q2 25 | $-6.7M | $12.8M | ||
| Q1 25 | $-490.0K | $26.3M | ||
| Q4 24 | $-3.8M | $18.1M | ||
| Q3 24 | $2.6M | $11.6M | ||
| Q2 24 | $-16.1M | $15.3M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 20.4% | — | ||
| Q2 25 | 20.4% | — | ||
| Q1 25 | 20.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 20.4% | — | ||
| Q2 24 | 20.8% | — |
| Q1 26 | — | 30.5% | ||
| Q4 25 | -30.2% | — | ||
| Q3 25 | -2.4% | — | ||
| Q2 25 | -2.1% | — | ||
| Q1 25 | -0.3% | — | ||
| Q4 24 | -1.1% | — | ||
| Q3 24 | 0.9% | — | ||
| Q2 24 | -5.7% | — |
| Q1 26 | — | 17.4% | ||
| Q4 25 | -35.0% | 25.3% | ||
| Q3 25 | -1.9% | 13.5% | ||
| Q2 25 | -2.4% | 7.2% | ||
| Q1 25 | -0.2% | 14.8% | ||
| Q4 24 | -1.2% | 10.5% | ||
| Q3 24 | 0.8% | 7.0% | ||
| Q2 24 | -4.7% | 9.5% |
| Q1 26 | — | $0.24 | ||
| Q4 25 | $-2.56 | $0.38 | ||
| Q3 25 | $-0.15 | $0.20 | ||
| Q2 25 | $-0.20 | $0.10 | ||
| Q1 25 | $-0.02 | $0.21 | ||
| Q4 24 | $-0.13 | $0.16 | ||
| Q3 24 | $0.08 | $0.09 | ||
| Q2 24 | $-0.47 | $0.12 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $108.7M | $3.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $322.8M | $2.3B |
| Total Assets | $449.0M | $5.4B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $3.1M | ||
| Q4 25 | $108.7M | $3.5M | ||
| Q3 25 | $99.1M | $4.1M | ||
| Q2 25 | $81.2M | $5.6M | ||
| Q1 25 | $80.7M | $5.5M | ||
| Q4 24 | $81.6M | $4.9M | ||
| Q3 24 | $64.0M | $6.4M | ||
| Q2 24 | $69.6M | $7.1M |
| Q1 26 | — | — | ||
| Q4 25 | — | $2.4B | ||
| Q3 25 | — | $2.4B | ||
| Q2 25 | — | $2.4B | ||
| Q1 25 | — | $2.3B | ||
| Q4 24 | — | $2.1B | ||
| Q3 24 | — | $2.1B | ||
| Q2 24 | — | $2.0B |
| Q1 26 | — | $2.3B | ||
| Q4 25 | $322.8M | $2.3B | ||
| Q3 25 | $408.1M | $2.3B | ||
| Q2 25 | $412.2M | $2.3B | ||
| Q1 25 | $418.2M | $2.3B | ||
| Q4 24 | $419.0M | $2.3B | ||
| Q3 24 | $424.7M | $2.2B | ||
| Q2 24 | $433.3M | $2.3B |
| Q1 26 | — | $5.4B | ||
| Q4 25 | $449.0M | $5.3B | ||
| Q3 25 | $538.2M | $5.3B | ||
| Q2 25 | $553.8M | $5.3B | ||
| Q1 25 | $576.2M | $5.2B | ||
| Q4 24 | $589.3M | $5.0B | ||
| Q3 24 | $597.4M | $5.0B | ||
| Q2 24 | $602.9M | $4.9B |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.04× | ||
| Q3 25 | — | 1.05× | ||
| Q2 25 | — | 1.04× | ||
| Q1 25 | — | 0.99× | ||
| Q4 24 | — | 0.91× | ||
| Q3 24 | — | 0.94× | ||
| Q2 24 | — | 0.90× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $18.2M | $55.6M |
| Free Cash FlowOCF − Capex | $16.1M | — |
| FCF MarginFCF / Revenue | 6.8% | — |
| Capex IntensityCapex / Revenue | 0.9% | 12.6% |
| Cash ConversionOCF / Net Profit | — | 1.67× |
| TTM Free Cash FlowTrailing 4 quarters | $40.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $55.6M | ||
| Q4 25 | $18.2M | $348.1M | ||
| Q3 25 | $20.1M | $95.4M | ||
| Q2 25 | $4.2M | $96.1M | ||
| Q1 25 | $5.7M | $60.5M | ||
| Q4 24 | $24.2M | $334.7M | ||
| Q3 24 | $7.5M | $109.1M | ||
| Q2 24 | $82.4M | $78.5M |
| Q1 26 | — | — | ||
| Q4 25 | $16.1M | — | ||
| Q3 25 | $17.9M | — | ||
| Q2 25 | $2.3M | — | ||
| Q1 25 | $3.8M | — | ||
| Q4 24 | $21.7M | — | ||
| Q3 24 | $6.3M | — | ||
| Q2 24 | $79.6M | — |
| Q1 26 | — | — | ||
| Q4 25 | 6.8% | — | ||
| Q3 25 | 7.2% | — | ||
| Q2 25 | 0.8% | — | ||
| Q1 25 | 1.3% | — | ||
| Q4 24 | 7.0% | — | ||
| Q3 24 | 2.0% | — | ||
| Q2 24 | 23.4% | — |
| Q1 26 | — | 12.6% | ||
| Q4 25 | 0.9% | — | ||
| Q3 25 | 0.9% | — | ||
| Q2 25 | 0.7% | — | ||
| Q1 25 | 0.6% | — | ||
| Q4 24 | 0.8% | — | ||
| Q3 24 | 0.4% | — | ||
| Q2 24 | 0.8% | — |
| Q1 26 | — | 1.67× | ||
| Q4 25 | — | 7.33× | ||
| Q3 25 | — | 3.87× | ||
| Q2 25 | — | 7.52× | ||
| Q1 25 | — | 2.30× | ||
| Q4 24 | — | 18.45× | ||
| Q3 24 | 2.92× | 9.40× | ||
| Q2 24 | — | 5.14× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
PECO
| Rental income | $186.3M | 98% |
| Fees and management income | $3.4M | 2% |
